January 11, 2024
WVXU highlighted a new trial at the University of Cincinnati that will test an at-home tongue endurance exercise to improve patients’ swallowing function after a stroke.
January 12, 2024
University of Cincinnati research on how eating strawberries can reduce dementia risk was featured in a "LIVE with Kelly and Mark" segment on superfoods to eat in 2024.
January 17, 2024
The University of Cincinnati Cancer Center’s Maria Czyzyk-Krzeska, MD, PhD, has been awarded a five-year, $2.8 million grant from the National Institutes of Health to investigate how copper contributes to the advancement and recurrence of clear cell renal cell carcinoma.
January 19, 2024
Precision Medicine Online highlighted a University of Cincinnati clinical trial applying a personalized approach to pain management that doctors hope can improve post-surgical pain, reduce opioid dependence and reduce length of hospital stays.
January 23, 2024
The Cancer Letter highlighted the University of Cincinnati Cancer Center’s Maria Czyzyk-Krzeska's new NIH-funded research that will investigate how copper contributes to the advancement and recurrence of clear cell renal cell carcinoma.
January 24, 2024
University of Cincinnati James L. Winkle College of Pharmacy alumna Samar Alanazi leaves a lasting legacy and made groundbreaking breast cancer research discoveries while battling her own cancer diagnosis since 2014.
January 24, 2024
The University of Cincinnati College of Pharmacy has launched the Steven A. Myre Endowed Scholarship Fund to honor the longtime professor's legacy.
January 25, 2024
Local 12 highlighted a partnership between the University of Cincinnati and Cincinnati Public Schools that is helping high school students earn class credit, and a potential paycheck, through pharmacy technician training.
January 31, 2024
The University of Cincinnati Blue Ash College's Jennifer Wells was a panelist on WVXU's Cincinnati Edition discussing a new drug being developed designed to extend the lives of dogs.
February 6, 2024
A new University of Cincinnati trial, in partnership with Spark Biomedical, will test a wearable neurostimulation device to help patients with opioid use disorder and post-traumatic stress disorder stick with medication treatment while finding the right dose.